Ownership history in Logos Global Management LP · 14 quarters on record
This page tracks every 13F SEC filing in which Logos Global Management LP reported a position in STRUCTURE THERAPEUTICS INC (GPCR). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 600,000 | -250,000 | -29.4% | 2.52% | $41.7M | $69.55 |
| 2025 Q3 | UNCHANGED | 850,000 | — | 0% | 2.13% | $23.8M | $28.00 |
| 2025 Q2 | ADDED | 850,000 | +425,000 | +100.0% | 1.95% | $17.6M | $20.74 |
| 2025 Q1 | REDUCED | 425,000 | -275,000 | -39.3% | 1.31% | $7.4M | $17.31 |
| 2024 Q4 | REDUCED | 700,000 | -550,000 | -44.0% | 2.22% | $19.0M | $27.12 |
| 2024 Q3 | ADDED | 1,250,000 | +800,000 | +177.8% | 5.92% | $54.9M | $43.89 |
| 2024 Q2 | REDUCED | 450,000 | -650,000 | -59.1% | 1.43% | $17.7M | $39.27 |
| 2024 Q2 | ADDED | 1,100,000 | +650,000 | +144.4% | 3.51% | $43.2M | $39.27 |
| 2024 Q1 | REDUCED | 450,000 | -270,058 | -37.5% | 1.56% | $19.3M | $42.86 |
| 2024 Q1 | REDUCED | 720,058 | -350,000 | -32.7% | 2.50% | $30.9M | $42.86 |
As of 2025 Q4 — sorted by position size